Liver resection after Transjugular Portosystemic Stent Shunt (TIPSS)

被引:2
作者
Sliwinski, Svenja [1 ]
Trojan, Joerg [2 ]
Mader, Christoph [3 ]
Vogl, Thomas [3 ]
Bechstein, Wolf [1 ]
机构
[1] Hosp Goethe Univ Frankfurt, Dept Gen Visceral Transplant & Thorac Surg, Frankfurt, Germany
[2] Hosp Goethe Univ Frankfurt, Dept Internal Med, Ctr Internal Med, Frankfurt, Germany
[3] Hosp Goethe Univ Frankfurt, Dept Radiol, Ctr Radiol, Frankfurt, Germany
来源
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2023年 / 61卷 / 04期
关键词
transjugular portosystemic stent shunt; hepatocellular carcinoma; liver cirrhosis; portal hypertension; liver resection; MANAGEMENT; CIRRHOSIS; SURGERY;
D O I
10.1055/a-1791-2192
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hcpatocellular carcinoma (HCC) often arises in cirrhotic livers. Generally, decompensated liver cirrhosis is a contraindication to surgery. Even in compensated liver cirrhosis, liver resection for HCC carries a high risk of post-hepatectomy liver failure and decompensation of cirrhosis. Thus, in current staging systems such as the Barcelona Classification of Liver Cancer (BCLC) or the Hong Kong Classification of Liver Cancer (HKLC), liver resection is limited to smaller tumors in compensated cirrhosis. While transjugular portosystemic stent shunts (TIPSS) are widely used for the treatment of complications of portal hypertension such as recurrent esophageal bleeding or refractory ascites, the presence of a TIPSS is generally considered a contraindication for liver resection. Herein, we describe - to our knowledge for the first time - liver resection of an intermediate HCC with a diameter of 11 cm in a patient who had previously received a TIPSS for decompensated cirrhosis. With open surgery, radical resection (R0) was able to be achieved, and the patient left the hospital after 6 days following an uncomplicated postoperative course. Thus, in highly selected cases, liver resection following TIPSS may be considered.
引用
收藏
页码:390 / 393
页数:4
相关论文
共 10 条
[1]   The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension [J].
Boyer, TD ;
Haskal, ZJ .
HEPATOLOGY, 2005, 41 (02) :386-400
[2]  
García-Pagán JC, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2020.100122
[3]   Transjugular intrahepatic portosystemic shunt before hepatic surgery in a patient with cirrhosis and portal hypertension: Case report [J].
Du Rieu, M. Chalret ;
Carrere, N. ;
Bureau, C. ;
Lagarde, S. ;
Otal, P. ;
Pradere, B. .
JOURNAL DE CHIRURGIE, 2009, 146 (02) :191-194
[4]   Recent advances in the surgical management of hepatocellular carcinoma [J].
Glantzounis, Georgios K. ;
Karampa, Anastasia ;
Peristeri, Dimitra, V ;
Pappas-Gogos, George ;
Tepelenis, Kostas ;
Tzimas, Petros ;
Cyrochristos, Dimitrios J. .
ANNALS OF GASTROENTEROLOGY, 2021, 34 (04) :453-465
[5]   Liver surgery in cirrhosis and portal hypertension [J].
Hackl, Christina ;
Schlitt, Hans J. ;
Renner, Philipp ;
Lang, Sven A. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (09) :2725-2735
[6]   A Glasgow Tipple-transjugular intrahepatic portosystemic shunt insertion prior to Whipple resection [J].
Jabbar, Salman A. A. ;
Jamieson, Nigel B. ;
Morris, Andrew J. ;
Oien, Karin A. ;
Duthie, Fraser ;
McKay, Colin J. ;
Carter, Christopher R. ;
Dickson, Euan J. .
JOURNAL OF SURGICAL CASE REPORTS, 2016, (05)
[7]   Preoperative elective transjugular intrahepatic portosystemic shunt for cirrhotic patients undergoing abdominal surgery [J].
Jain, Deepanshu ;
Mahmood, Ejaz ;
V-Bandres, Maria ;
Feyssa, Eyob .
ANNALS OF GASTROENTEROLOGY, 2018, 31 (03) :330-337
[8]   Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective [J].
Li, James Weiquan ;
Goh, Boon-Bee George ;
Chang, Pik-Eu ;
Tan, Chee-Kiat .
WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (22) :4054-4063
[9]  
Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.19, 10.1038/nrdp.2016.18]
[10]  
RICHTER GM, 1989, RADIOLOGE, V29, P406